nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA2—osteoporosis	0.389	1	CbGaD
Topiramate—CA12—Zoledronate—osteoporosis	0.127	0.394	CbGbCtD
Topiramate—CA2—Zoledronate—osteoporosis	0.103	0.319	CbGbCtD
Topiramate—CYP2C19—Cholecalciferol—osteoporosis	0.0133	0.041	CbGbCtD
Topiramate—CYP3A4—Estropipate—osteoporosis	0.0124	0.0385	CbGbCtD
Topiramate—CYP3A4—Calcitriol—osteoporosis	0.0124	0.0385	CbGbCtD
Topiramate—CYP2C19—Estradiol—osteoporosis	0.0107	0.0331	CbGbCtD
Topiramate—CYP3A4—Ergocalciferol—osteoporosis	0.00995	0.0308	CbGbCtD
Topiramate—CYP3A4—Raloxifene—osteoporosis	0.00831	0.0257	CbGbCtD
Topiramate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00802	0.0248	CbGbCtD
Topiramate—CYP3A4—Cholecalciferol—osteoporosis	0.00641	0.0198	CbGbCtD
Topiramate—CYP3A4—Conjugated Estrogens—osteoporosis	0.00589	0.0182	CbGbCtD
Topiramate—CYP3A4—Estradiol—osteoporosis	0.00517	0.016	CbGbCtD
Topiramate—Convulsion—Conjugated Estrogens—osteoporosis	6.43e-05	0.000294	CcSEcCtD
Topiramate—Dry mouth—Zoledronate—osteoporosis	6.42e-05	0.000294	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	6.42e-05	0.000294	CcSEcCtD
Topiramate—Fatigue—Ethinyl Estradiol—osteoporosis	6.41e-05	0.000293	CcSEcCtD
Topiramate—Pruritus—Alendronate—osteoporosis	6.39e-05	0.000292	CcSEcCtD
Topiramate—Dyspepsia—Risedronate—osteoporosis	6.38e-05	0.000292	CcSEcCtD
Topiramate—Eye disorder—Estradiol—osteoporosis	6.38e-05	0.000292	CcSEcCtD
Topiramate—Tinnitus—Estradiol—osteoporosis	6.36e-05	0.000291	CcSEcCtD
Topiramate—Constipation—Ethinyl Estradiol—osteoporosis	6.36e-05	0.000291	CcSEcCtD
Topiramate—Confusional state—Zoledronate—osteoporosis	6.35e-05	0.00029	CcSEcCtD
Topiramate—Hypersensitivity—Calcitriol—osteoporosis	6.34e-05	0.00029	CcSEcCtD
Topiramate—Flushing—Estradiol—osteoporosis	6.34e-05	0.00029	CcSEcCtD
Topiramate—Cardiac disorder—Estradiol—osteoporosis	6.34e-05	0.00029	CcSEcCtD
Topiramate—Arthralgia—Conjugated Estrogens—osteoporosis	6.32e-05	0.000289	CcSEcCtD
Topiramate—Chest pain—Conjugated Estrogens—osteoporosis	6.32e-05	0.000289	CcSEcCtD
Topiramate—Myalgia—Conjugated Estrogens—osteoporosis	6.32e-05	0.000289	CcSEcCtD
Topiramate—Asthenia—Ibandronate—osteoporosis	6.31e-05	0.000289	CcSEcCtD
Topiramate—Anxiety—Conjugated Estrogens—osteoporosis	6.3e-05	0.000288	CcSEcCtD
Topiramate—Nausea—Etidronic acid—osteoporosis	6.3e-05	0.000288	CcSEcCtD
Topiramate—Oedema—Zoledronate—osteoporosis	6.29e-05	0.000288	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	6.28e-05	0.000287	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Pamidronate—osteoporosis	6.28e-05	0.000287	CcSEcCtD
Topiramate—Diarrhoea—Estropipate—osteoporosis	6.27e-05	0.000287	CcSEcCtD
Topiramate—Gastrointestinal disorder—Risedronate—osteoporosis	6.26e-05	0.000286	CcSEcCtD
Topiramate—Infection—Zoledronate—osteoporosis	6.25e-05	0.000286	CcSEcCtD
Topiramate—Fatigue—Risedronate—osteoporosis	6.25e-05	0.000286	CcSEcCtD
Topiramate—Insomnia—Pamidronate—osteoporosis	6.23e-05	0.000285	CcSEcCtD
Topiramate—Pruritus—Ibandronate—osteoporosis	6.22e-05	0.000285	CcSEcCtD
Topiramate—Pain—Risedronate—osteoporosis	6.2e-05	0.000284	CcSEcCtD
Topiramate—Constipation—Risedronate—osteoporosis	6.2e-05	0.000284	CcSEcCtD
Topiramate—Angiopathy—Estradiol—osteoporosis	6.19e-05	0.000283	CcSEcCtD
Topiramate—Shock—Zoledronate—osteoporosis	6.19e-05	0.000283	CcSEcCtD
Topiramate—Paraesthesia—Pamidronate—osteoporosis	6.19e-05	0.000283	CcSEcCtD
Topiramate—Diarrhoea—Alendronate—osteoporosis	6.18e-05	0.000283	CcSEcCtD
Topiramate—Asthenia—Calcitriol—osteoporosis	6.18e-05	0.000283	CcSEcCtD
Topiramate—Nervous system disorder—Zoledronate—osteoporosis	6.17e-05	0.000282	CcSEcCtD
Topiramate—Immune system disorder—Estradiol—osteoporosis	6.17e-05	0.000282	CcSEcCtD
Topiramate—Thrombocytopenia—Zoledronate—osteoporosis	6.16e-05	0.000282	CcSEcCtD
Topiramate—Mediastinal disorder—Estradiol—osteoporosis	6.15e-05	0.000282	CcSEcCtD
Topiramate—Dyspnoea—Pamidronate—osteoporosis	6.14e-05	0.000281	CcSEcCtD
Topiramate—Tachycardia—Zoledronate—osteoporosis	6.14e-05	0.000281	CcSEcCtD
Topiramate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	6.13e-05	0.00028	CcSEcCtD
Topiramate—Chills—Estradiol—osteoporosis	6.13e-05	0.00028	CcSEcCtD
Topiramate—Somnolence—Pamidronate—osteoporosis	6.12e-05	0.00028	CcSEcCtD
Topiramate—Skin disorder—Zoledronate—osteoporosis	6.11e-05	0.00028	CcSEcCtD
Topiramate—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	6.1e-05	0.000876	CbGpPWpGaD
Topiramate—Pruritus—Calcitriol—osteoporosis	6.09e-05	0.000279	CcSEcCtD
Topiramate—Hyperhidrosis—Zoledronate—osteoporosis	6.08e-05	0.000278	CcSEcCtD
Topiramate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	6.08e-05	0.000278	CcSEcCtD
Topiramate—Diarrhoea—Raloxifene—osteoporosis	6.08e-05	0.000278	CcSEcCtD
Topiramate—CA5B—Metabolism—ACP5—osteoporosis	6.07e-05	0.000872	CbGpPWpGaD
Topiramate—CA7—Metabolism—ACP5—osteoporosis	6.07e-05	0.000872	CbGpPWpGaD
Topiramate—Dyspepsia—Pamidronate—osteoporosis	6.06e-05	0.000278	CcSEcCtD
Topiramate—Dizziness—Estropipate—osteoporosis	6.06e-05	0.000278	CcSEcCtD
Topiramate—Oedema—Conjugated Estrogens—osteoporosis	6.06e-05	0.000277	CcSEcCtD
Topiramate—CA5A—Metabolism—TPI1—osteoporosis	6.04e-05	0.000869	CbGpPWpGaD
Topiramate—CA6—Metabolism—TPI1—osteoporosis	6.04e-05	0.000869	CbGpPWpGaD
Topiramate—Alopecia—Estradiol—osteoporosis	6.03e-05	0.000276	CcSEcCtD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.03e-05	0.000867	CbGpPWpGaD
Topiramate—Infection—Conjugated Estrogens—osteoporosis	6.02e-05	0.000276	CcSEcCtD
Topiramate—Diarrhoea—Ibandronate—osteoporosis	6.02e-05	0.000275	CcSEcCtD
Topiramate—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	6.01e-05	0.000864	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	6e-05	0.000863	CbGpPWpGaD
Topiramate—Anorexia—Zoledronate—osteoporosis	6e-05	0.000275	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6R—osteoporosis	6e-05	0.000862	CbGpPWpGaD
Topiramate—Decreased appetite—Pamidronate—osteoporosis	5.99e-05	0.000274	CcSEcCtD
Topiramate—Mental disorder—Estradiol—osteoporosis	5.98e-05	0.000274	CcSEcCtD
Topiramate—Dizziness—Alendronate—osteoporosis	5.97e-05	0.000273	CcSEcCtD
Topiramate—Shock—Conjugated Estrogens—osteoporosis	5.96e-05	0.000273	CcSEcCtD
Topiramate—Gastrointestinal disorder—Pamidronate—osteoporosis	5.95e-05	0.000272	CcSEcCtD
Topiramate—Nervous system disorder—Conjugated Estrogens—osteoporosis	5.94e-05	0.000272	CcSEcCtD
Topiramate—Malnutrition—Estradiol—osteoporosis	5.94e-05	0.000272	CcSEcCtD
Topiramate—Erythema—Estradiol—osteoporosis	5.94e-05	0.000272	CcSEcCtD
Topiramate—Fatigue—Pamidronate—osteoporosis	5.94e-05	0.000272	CcSEcCtD
Topiramate—Gastrointestinal pain—Risedronate—osteoporosis	5.93e-05	0.000271	CcSEcCtD
Topiramate—CA4—Metabolism—CA2—osteoporosis	5.92e-05	0.00085	CbGpPWpGaD
Topiramate—CA4—Metabolism—OXCT1—osteoporosis	5.92e-05	0.00085	CbGpPWpGaD
Topiramate—Tachycardia—Conjugated Estrogens—osteoporosis	5.91e-05	0.000271	CcSEcCtD
Topiramate—Urticaria—Ethinyl Estradiol—osteoporosis	5.91e-05	0.00027	CcSEcCtD
Topiramate—Pain—Pamidronate—osteoporosis	5.89e-05	0.00027	CcSEcCtD
Topiramate—Constipation—Pamidronate—osteoporosis	5.89e-05	0.00027	CcSEcCtD
Topiramate—Diarrhoea—Calcitriol—osteoporosis	5.89e-05	0.00027	CcSEcCtD
Topiramate—Skin disorder—Conjugated Estrogens—osteoporosis	5.89e-05	0.000269	CcSEcCtD
Topiramate—Hypotension—Zoledronate—osteoporosis	5.88e-05	0.000269	CcSEcCtD
Topiramate—Body temperature increased—Ethinyl Estradiol—osteoporosis	5.88e-05	0.000269	CcSEcCtD
Topiramate—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.88e-05	0.000269	CcSEcCtD
Topiramate—Dizziness—Raloxifene—osteoporosis	5.87e-05	0.000269	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—WNT1—osteoporosis	5.87e-05	0.000843	CbGpPWpGaD
Topiramate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.86e-05	0.000268	CcSEcCtD
Topiramate—Flatulence—Estradiol—osteoporosis	5.86e-05	0.000268	CcSEcCtD
Topiramate—Tension—Estradiol—osteoporosis	5.83e-05	0.000267	CcSEcCtD
Topiramate—Vomiting—Estropipate—osteoporosis	5.83e-05	0.000267	CcSEcCtD
Topiramate—Dysgeusia—Estradiol—osteoporosis	5.82e-05	0.000266	CcSEcCtD
Topiramate—Dizziness—Ibandronate—osteoporosis	5.82e-05	0.000266	CcSEcCtD
Topiramate—Rash—Estropipate—osteoporosis	5.78e-05	0.000265	CcSEcCtD
Topiramate—CA12—Metabolism—CYP27A1—osteoporosis	5.78e-05	0.000831	CbGpPWpGaD
Topiramate—Dermatitis—Estropipate—osteoporosis	5.78e-05	0.000264	CcSEcCtD
Topiramate—Anorexia—Conjugated Estrogens—osteoporosis	5.78e-05	0.000264	CcSEcCtD
Topiramate—Nervousness—Estradiol—osteoporosis	5.77e-05	0.000264	CcSEcCtD
Topiramate—CA4—Metabolism—MGLL—osteoporosis	5.77e-05	0.000829	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—ADCY5—osteoporosis	5.76e-05	0.000828	CbGpPWpGaD
Topiramate—Urticaria—Risedronate—osteoporosis	5.76e-05	0.000263	CcSEcCtD
Topiramate—Back pain—Estradiol—osteoporosis	5.75e-05	0.000263	CcSEcCtD
Topiramate—Headache—Estropipate—osteoporosis	5.75e-05	0.000263	CcSEcCtD
Topiramate—Vomiting—Alendronate—osteoporosis	5.74e-05	0.000263	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Zoledronate—osteoporosis	5.73e-05	0.000262	CcSEcCtD
Topiramate—Abdominal pain—Risedronate—osteoporosis	5.73e-05	0.000262	CcSEcCtD
Topiramate—Body temperature increased—Risedronate—osteoporosis	5.73e-05	0.000262	CcSEcCtD
Topiramate—Muscle spasms—Estradiol—osteoporosis	5.71e-05	0.000261	CcSEcCtD
Topiramate—Rash—Alendronate—osteoporosis	5.7e-05	0.000261	CcSEcCtD
Topiramate—Insomnia—Zoledronate—osteoporosis	5.69e-05	0.00026	CcSEcCtD
Topiramate—Dermatitis—Alendronate—osteoporosis	5.69e-05	0.00026	CcSEcCtD
Topiramate—CA6—Metabolism—P4HB—osteoporosis	5.68e-05	0.000817	CbGpPWpGaD
Topiramate—CA5A—Metabolism—P4HB—osteoporosis	5.68e-05	0.000817	CbGpPWpGaD
Topiramate—Feeling abnormal—Pamidronate—osteoporosis	5.68e-05	0.00026	CcSEcCtD
Topiramate—CA2—Metabolism—OXCT1—osteoporosis	5.67e-05	0.000815	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.67e-05	0.000815	CbGpPWpGaD
Topiramate—Hypotension—Conjugated Estrogens—osteoporosis	5.66e-05	0.000259	CcSEcCtD
Topiramate—Headache—Alendronate—osteoporosis	5.66e-05	0.000259	CcSEcCtD
Topiramate—Paraesthesia—Zoledronate—osteoporosis	5.65e-05	0.000259	CcSEcCtD
Topiramate—Vomiting—Raloxifene—osteoporosis	5.65e-05	0.000258	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.65e-05	0.000812	CbGpPWpGaD
Topiramate—CA7—Metabolism—TPI1—osteoporosis	5.64e-05	0.000811	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TPI1—osteoporosis	5.64e-05	0.000811	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Pamidronate—osteoporosis	5.63e-05	0.000258	CcSEcCtD
Topiramate—CA9—Metabolism—PNP—osteoporosis	5.62e-05	0.000808	CbGpPWpGaD
Topiramate—CA9—Metabolism—ATIC—osteoporosis	5.62e-05	0.000808	CbGpPWpGaD
Topiramate—CA12—Metabolism—ACP5—osteoporosis	5.62e-05	0.000808	CbGpPWpGaD
Topiramate—Dyspnoea—Zoledronate—osteoporosis	5.61e-05	0.000257	CcSEcCtD
Topiramate—Rash—Raloxifene—osteoporosis	5.6e-05	0.000256	CcSEcCtD
Topiramate—Dermatitis—Raloxifene—osteoporosis	5.6e-05	0.000256	CcSEcCtD
Topiramate—Somnolence—Zoledronate—osteoporosis	5.59e-05	0.000256	CcSEcCtD
Topiramate—Vomiting—Ibandronate—osteoporosis	5.59e-05	0.000256	CcSEcCtD
Topiramate—CA5A—Metabolism—GAPDH—osteoporosis	5.58e-05	0.000802	CbGpPWpGaD
Topiramate—CA6—Metabolism—GAPDH—osteoporosis	5.58e-05	0.000802	CbGpPWpGaD
Topiramate—Tremor—Estradiol—osteoporosis	5.57e-05	0.000255	CcSEcCtD
Topiramate—Headache—Raloxifene—osteoporosis	5.57e-05	0.000255	CcSEcCtD
Topiramate—Rash—Ibandronate—osteoporosis	5.54e-05	0.000254	CcSEcCtD
Topiramate—Dermatitis—Ibandronate—osteoporosis	5.54e-05	0.000254	CcSEcCtD
Topiramate—Dyspepsia—Zoledronate—osteoporosis	5.54e-05	0.000254	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	5.53e-05	0.000795	CbGpPWpGaD
Topiramate—CA2—Metabolism—MGLL—osteoporosis	5.53e-05	0.000795	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	5.52e-05	0.000253	CcSEcCtD
Topiramate—Ill-defined disorder—Estradiol—osteoporosis	5.51e-05	0.000252	CcSEcCtD
Topiramate—Headache—Ibandronate—osteoporosis	5.51e-05	0.000252	CcSEcCtD
Topiramate—Insomnia—Conjugated Estrogens—osteoporosis	5.48e-05	0.000251	CcSEcCtD
Topiramate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5.48e-05	0.000251	CcSEcCtD
Topiramate—Vomiting—Calcitriol—osteoporosis	5.47e-05	0.00025	CcSEcCtD
Topiramate—Decreased appetite—Zoledronate—osteoporosis	5.47e-05	0.00025	CcSEcCtD
Topiramate—Agitation—Estradiol—osteoporosis	5.46e-05	0.00025	CcSEcCtD
Topiramate—Nausea—Estropipate—osteoporosis	5.45e-05	0.000249	CcSEcCtD
Topiramate—Body temperature increased—Pamidronate—osteoporosis	5.45e-05	0.000249	CcSEcCtD
Topiramate—Abdominal pain—Pamidronate—osteoporosis	5.45e-05	0.000249	CcSEcCtD
Topiramate—Paraesthesia—Conjugated Estrogens—osteoporosis	5.44e-05	0.000249	CcSEcCtD
Topiramate—CA1—Metabolism—OXCT1—osteoporosis	5.44e-05	0.000782	CbGpPWpGaD
Topiramate—CA1—Metabolism—CA2—osteoporosis	5.44e-05	0.000782	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Zoledronate—osteoporosis	5.43e-05	0.000249	CcSEcCtD
Topiramate—CA5A—Metabolism—RAP1A—osteoporosis	5.43e-05	0.000781	CbGpPWpGaD
Topiramate—CA6—Metabolism—RAP1A—osteoporosis	5.43e-05	0.000781	CbGpPWpGaD
Topiramate—Rash—Calcitriol—osteoporosis	5.43e-05	0.000248	CcSEcCtD
Topiramate—Fatigue—Zoledronate—osteoporosis	5.43e-05	0.000248	CcSEcCtD
Topiramate—Dermatitis—Calcitriol—osteoporosis	5.42e-05	0.000248	CcSEcCtD
Topiramate—Dyspnoea—Conjugated Estrogens—osteoporosis	5.4e-05	0.000247	CcSEcCtD
Topiramate—Headache—Calcitriol—osteoporosis	5.39e-05	0.000247	CcSEcCtD
Topiramate—Somnolence—Conjugated Estrogens—osteoporosis	5.39e-05	0.000247	CcSEcCtD
Topiramate—Constipation—Zoledronate—osteoporosis	5.38e-05	0.000246	CcSEcCtD
Topiramate—Pain—Zoledronate—osteoporosis	5.38e-05	0.000246	CcSEcCtD
Topiramate—Nausea—Alendronate—osteoporosis	5.37e-05	0.000246	CcSEcCtD
Topiramate—Malaise—Estradiol—osteoporosis	5.36e-05	0.000245	CcSEcCtD
Topiramate—Hypersensitivity—Risedronate—osteoporosis	5.34e-05	0.000244	CcSEcCtD
Topiramate—Vertigo—Estradiol—osteoporosis	5.34e-05	0.000244	CcSEcCtD
Topiramate—Dyspepsia—Conjugated Estrogens—osteoporosis	5.33e-05	0.000244	CcSEcCtD
Topiramate—Asthenia—Ethinyl Estradiol—osteoporosis	5.33e-05	0.000244	CcSEcCtD
Topiramate—Syncope—Estradiol—osteoporosis	5.33e-05	0.000244	CcSEcCtD
Topiramate—CA5B—Metabolism—P4HB—osteoporosis	5.3e-05	0.000763	CbGpPWpGaD
Topiramate—CA7—Metabolism—P4HB—osteoporosis	5.3e-05	0.000763	CbGpPWpGaD
Topiramate—CA1—Metabolism—MGLL—osteoporosis	5.3e-05	0.000762	CbGpPWpGaD
Topiramate—Nausea—Raloxifene—osteoporosis	5.28e-05	0.000241	CcSEcCtD
Topiramate—Decreased appetite—Conjugated Estrogens—osteoporosis	5.27e-05	0.000241	CcSEcCtD
Topiramate—Pruritus—Ethinyl Estradiol—osteoporosis	5.26e-05	0.000241	CcSEcCtD
Topiramate—Palpitations—Estradiol—osteoporosis	5.25e-05	0.00024	CcSEcCtD
Topiramate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	5.23e-05	0.000239	CcSEcCtD
Topiramate—CA12—Metabolism—TPI1—osteoporosis	5.23e-05	0.000751	CbGpPWpGaD
Topiramate—Fatigue—Conjugated Estrogens—osteoporosis	5.22e-05	0.000239	CcSEcCtD
Topiramate—Nausea—Ibandronate—osteoporosis	5.22e-05	0.000239	CcSEcCtD
Topiramate—Loss of consciousness—Estradiol—osteoporosis	5.22e-05	0.000239	CcSEcCtD
Topiramate—CA7—Metabolism—GAPDH—osteoporosis	5.21e-05	0.000748	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GAPDH—osteoporosis	5.21e-05	0.000748	CbGpPWpGaD
Topiramate—Asthenia—Risedronate—osteoporosis	5.2e-05	0.000238	CcSEcCtD
Topiramate—Feeling abnormal—Zoledronate—osteoporosis	5.19e-05	0.000237	CcSEcCtD
Topiramate—Cough—Estradiol—osteoporosis	5.19e-05	0.000237	CcSEcCtD
Topiramate—Constipation—Conjugated Estrogens—osteoporosis	5.18e-05	0.000237	CcSEcCtD
Topiramate—Pain—Conjugated Estrogens—osteoporosis	5.18e-05	0.000237	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.16e-05	0.000742	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Zoledronate—osteoporosis	5.15e-05	0.000236	CcSEcCtD
Topiramate—Hypertension—Estradiol—osteoporosis	5.13e-05	0.000235	CcSEcCtD
Topiramate—Pruritus—Risedronate—osteoporosis	5.13e-05	0.000235	CcSEcCtD
Topiramate—Nausea—Calcitriol—osteoporosis	5.11e-05	0.000234	CcSEcCtD
Topiramate—Diarrhoea—Ethinyl Estradiol—osteoporosis	5.09e-05	0.000233	CcSEcCtD
Topiramate—Hypersensitivity—Pamidronate—osteoporosis	5.08e-05	0.000232	CcSEcCtD
Topiramate—CA5B—Metabolism—RAP1A—osteoporosis	5.07e-05	0.000729	CbGpPWpGaD
Topiramate—CA7—Metabolism—RAP1A—osteoporosis	5.07e-05	0.000729	CbGpPWpGaD
Topiramate—Myalgia—Estradiol—osteoporosis	5.06e-05	0.000232	CcSEcCtD
Topiramate—Arthralgia—Estradiol—osteoporosis	5.06e-05	0.000232	CcSEcCtD
Topiramate—Chest pain—Estradiol—osteoporosis	5.06e-05	0.000232	CcSEcCtD
Topiramate—Anxiety—Estradiol—osteoporosis	5.04e-05	0.000231	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	5.02e-05	0.00023	CcSEcCtD
Topiramate—Urticaria—Zoledronate—osteoporosis	5e-05	0.000229	CcSEcCtD
Topiramate—Discomfort—Estradiol—osteoporosis	5e-05	0.000229	CcSEcCtD
Topiramate—Abdominal pain—Zoledronate—osteoporosis	4.97e-05	0.000228	CcSEcCtD
Topiramate—Body temperature increased—Zoledronate—osteoporosis	4.97e-05	0.000228	CcSEcCtD
Topiramate—Diarrhoea—Risedronate—osteoporosis	4.96e-05	0.000227	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.96e-05	0.000712	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.96e-05	0.000227	CcSEcCtD
Topiramate—Dry mouth—Estradiol—osteoporosis	4.95e-05	0.000226	CcSEcCtD
Topiramate—Asthenia—Pamidronate—osteoporosis	4.94e-05	0.000226	CcSEcCtD
Topiramate—Dizziness—Ethinyl Estradiol—osteoporosis	4.92e-05	0.000225	CcSEcCtD
Topiramate—CA12—Metabolism—P4HB—osteoporosis	4.91e-05	0.000706	CbGpPWpGaD
Topiramate—CA4—Metabolism—IDH2—osteoporosis	4.9e-05	0.000705	CbGpPWpGaD
Topiramate—Confusional state—Estradiol—osteoporosis	4.89e-05	0.000224	CcSEcCtD
Topiramate—Pruritus—Pamidronate—osteoporosis	4.87e-05	0.000223	CcSEcCtD
Topiramate—Oedema—Estradiol—osteoporosis	4.85e-05	0.000222	CcSEcCtD
Topiramate—CA12—Metabolism—GAPDH—osteoporosis	4.82e-05	0.000693	CbGpPWpGaD
Topiramate—Infection—Estradiol—osteoporosis	4.82e-05	0.00022	CcSEcCtD
Topiramate—Urticaria—Conjugated Estrogens—osteoporosis	4.81e-05	0.00022	CcSEcCtD
Topiramate—Dizziness—Risedronate—osteoporosis	4.79e-05	0.000219	CcSEcCtD
Topiramate—Abdominal pain—Conjugated Estrogens—osteoporosis	4.79e-05	0.000219	CcSEcCtD
Topiramate—Body temperature increased—Conjugated Estrogens—osteoporosis	4.79e-05	0.000219	CcSEcCtD
Topiramate—CA9—Metabolism—CA2—osteoporosis	4.78e-05	0.000687	CbGpPWpGaD
Topiramate—CA9—Metabolism—OXCT1—osteoporosis	4.78e-05	0.000687	CbGpPWpGaD
Topiramate—Shock—Estradiol—osteoporosis	4.77e-05	0.000218	CcSEcCtD
Topiramate—Nervous system disorder—Estradiol—osteoporosis	4.76e-05	0.000218	CcSEcCtD
Topiramate—SCN1A—Axon guidance—IL6R—osteoporosis	4.75e-05	0.000683	CbGpPWpGaD
Topiramate—Tachycardia—Estradiol—osteoporosis	4.73e-05	0.000217	CcSEcCtD
Topiramate—Vomiting—Ethinyl Estradiol—osteoporosis	4.73e-05	0.000216	CcSEcCtD
Topiramate—Diarrhoea—Pamidronate—osteoporosis	4.71e-05	0.000216	CcSEcCtD
Topiramate—Skin disorder—Estradiol—osteoporosis	4.71e-05	0.000216	CcSEcCtD
Topiramate—CA2—Metabolism—IDH2—osteoporosis	4.7e-05	0.000676	CbGpPWpGaD
Topiramate—CA12—Metabolism—RAP1A—osteoporosis	4.7e-05	0.000675	CbGpPWpGaD
Topiramate—Hyperhidrosis—Estradiol—osteoporosis	4.69e-05	0.000215	CcSEcCtD
Topiramate—Rash—Ethinyl Estradiol—osteoporosis	4.69e-05	0.000214	CcSEcCtD
Topiramate—Dermatitis—Ethinyl Estradiol—osteoporosis	4.68e-05	0.000214	CcSEcCtD
Topiramate—CA9—Metabolism—MGLL—osteoporosis	4.66e-05	0.00067	CbGpPWpGaD
Topiramate—Headache—Ethinyl Estradiol—osteoporosis	4.66e-05	0.000213	CcSEcCtD
Topiramate—Hypersensitivity—Zoledronate—osteoporosis	4.64e-05	0.000212	CcSEcCtD
Topiramate—CA4—Metabolism—CYP27A1—osteoporosis	4.61e-05	0.000663	CbGpPWpGaD
Topiramate—Vomiting—Risedronate—osteoporosis	4.61e-05	0.000211	CcSEcCtD
Topiramate—Rash—Risedronate—osteoporosis	4.57e-05	0.000209	CcSEcCtD
Topiramate—Dermatitis—Risedronate—osteoporosis	4.57e-05	0.000209	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.56e-05	0.000656	CbGpPWpGaD
Topiramate—Dizziness—Pamidronate—osteoporosis	4.56e-05	0.000209	CcSEcCtD
Topiramate—Headache—Risedronate—osteoporosis	4.54e-05	0.000208	CcSEcCtD
Topiramate—Asthenia—Zoledronate—osteoporosis	4.52e-05	0.000207	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	4.51e-05	0.000649	CbGpPWpGaD
Topiramate—CA1—Metabolism—IDH2—osteoporosis	4.51e-05	0.000648	CbGpPWpGaD
Topiramate—CA4—Metabolism—ACP5—osteoporosis	4.48e-05	0.000645	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.47e-05	0.000643	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.47e-05	0.000643	CbGpPWpGaD
Topiramate—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.46e-05	0.000204	CcSEcCtD
Topiramate—Pruritus—Zoledronate—osteoporosis	4.45e-05	0.000204	CcSEcCtD
Topiramate—CA2—Metabolism—CYP27A1—osteoporosis	4.42e-05	0.000635	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Estradiol—osteoporosis	4.42e-05	0.000202	CcSEcCtD
Topiramate—Nausea—Ethinyl Estradiol—osteoporosis	4.42e-05	0.000202	CcSEcCtD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.41e-05	0.000634	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ENO1—osteoporosis	4.39e-05	0.000631	CbGpPWpGaD
Topiramate—CA6—Metabolism—ENO1—osteoporosis	4.39e-05	0.000631	CbGpPWpGaD
Topiramate—Insomnia—Estradiol—osteoporosis	4.39e-05	0.000201	CcSEcCtD
Topiramate—Vomiting—Pamidronate—osteoporosis	4.38e-05	0.0002	CcSEcCtD
Topiramate—Paraesthesia—Estradiol—osteoporosis	4.35e-05	0.000199	CcSEcCtD
Topiramate—Asthenia—Conjugated Estrogens—osteoporosis	4.35e-05	0.000199	CcSEcCtD
Topiramate—Rash—Pamidronate—osteoporosis	4.34e-05	0.000199	CcSEcCtD
Topiramate—Dermatitis—Pamidronate—osteoporosis	4.34e-05	0.000199	CcSEcCtD
Topiramate—CA5A—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000622	CbGpPWpGaD
Topiramate—CA6—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000622	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000622	CbGpPWpGaD
Topiramate—CA6—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000622	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—ADCY5—osteoporosis	4.33e-05	0.000622	CbGpPWpGaD
Topiramate—Dyspnoea—Estradiol—osteoporosis	4.32e-05	0.000198	CcSEcCtD
Topiramate—Headache—Pamidronate—osteoporosis	4.32e-05	0.000198	CcSEcCtD
Topiramate—Somnolence—Estradiol—osteoporosis	4.31e-05	0.000197	CcSEcCtD
Topiramate—Diarrhoea—Zoledronate—osteoporosis	4.31e-05	0.000197	CcSEcCtD
Topiramate—Nausea—Risedronate—osteoporosis	4.3e-05	0.000197	CcSEcCtD
Topiramate—CA2—Metabolism—ACP5—osteoporosis	4.3e-05	0.000618	CbGpPWpGaD
Topiramate—Pruritus—Conjugated Estrogens—osteoporosis	4.29e-05	0.000196	CcSEcCtD
Topiramate—Dyspepsia—Estradiol—osteoporosis	4.27e-05	0.000195	CcSEcCtD
Topiramate—CA1—Metabolism—CYP27A1—osteoporosis	4.24e-05	0.000609	CbGpPWpGaD
Topiramate—Decreased appetite—Estradiol—osteoporosis	4.22e-05	0.000193	CcSEcCtD
Topiramate—Gastrointestinal disorder—Estradiol—osteoporosis	4.19e-05	0.000192	CcSEcCtD
Topiramate—Fatigue—Estradiol—osteoporosis	4.18e-05	0.000191	CcSEcCtD
Topiramate—CA4—Metabolism—TPI1—osteoporosis	4.17e-05	0.000599	CbGpPWpGaD
Topiramate—Dizziness—Zoledronate—osteoporosis	4.16e-05	0.00019	CcSEcCtD
Topiramate—Pain—Estradiol—osteoporosis	4.15e-05	0.00019	CcSEcCtD
Topiramate—Constipation—Estradiol—osteoporosis	4.15e-05	0.00019	CcSEcCtD
Topiramate—Diarrhoea—Conjugated Estrogens—osteoporosis	4.15e-05	0.00019	CcSEcCtD
Topiramate—CA1—Metabolism—ACP5—osteoporosis	4.12e-05	0.000592	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ENO1—osteoporosis	4.1e-05	0.000589	CbGpPWpGaD
Topiramate—CA7—Metabolism—ENO1—osteoporosis	4.1e-05	0.000589	CbGpPWpGaD
Topiramate—Nausea—Pamidronate—osteoporosis	4.09e-05	0.000187	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.08e-05	0.000586	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—LEP—osteoporosis	4.05e-05	0.000582	CbGpPWpGaD
Topiramate—CA7—Metabolism—PSMA5—osteoporosis	4.04e-05	0.000581	CbGpPWpGaD
Topiramate—CA7—Metabolism—PSMA2—osteoporosis	4.04e-05	0.000581	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PSMA5—osteoporosis	4.04e-05	0.000581	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PSMA2—osteoporosis	4.04e-05	0.000581	CbGpPWpGaD
Topiramate—Dizziness—Conjugated Estrogens—osteoporosis	4.01e-05	0.000183	CcSEcCtD
Topiramate—Vomiting—Zoledronate—osteoporosis	4e-05	0.000183	CcSEcCtD
Topiramate—Feeling abnormal—Estradiol—osteoporosis	4e-05	0.000183	CcSEcCtD
Topiramate—CA2—Metabolism—TPI1—osteoporosis	4e-05	0.000574	CbGpPWpGaD
Topiramate—Rash—Zoledronate—osteoporosis	3.97e-05	0.000182	CcSEcCtD
Topiramate—Gastrointestinal pain—Estradiol—osteoporosis	3.97e-05	0.000181	CcSEcCtD
Topiramate—Dermatitis—Zoledronate—osteoporosis	3.96e-05	0.000181	CcSEcCtD
Topiramate—CA9—Metabolism—IDH2—osteoporosis	3.96e-05	0.000569	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—ADCY5—osteoporosis	3.96e-05	0.000569	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.95e-05	0.000568	CbGpPWpGaD
Topiramate—Headache—Zoledronate—osteoporosis	3.94e-05	0.00018	CcSEcCtD
Topiramate—CA4—Metabolism—P4HB—osteoporosis	3.92e-05	0.000563	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.86e-05	0.000555	CbGpPWpGaD
Topiramate—Vomiting—Conjugated Estrogens—osteoporosis	3.85e-05	0.000176	CcSEcCtD
Topiramate—Urticaria—Estradiol—osteoporosis	3.85e-05	0.000176	CcSEcCtD
Topiramate—CA4—Metabolism—GAPDH—osteoporosis	3.85e-05	0.000553	CbGpPWpGaD
Topiramate—Body temperature increased—Estradiol—osteoporosis	3.83e-05	0.000175	CcSEcCtD
Topiramate—Abdominal pain—Estradiol—osteoporosis	3.83e-05	0.000175	CcSEcCtD
Topiramate—CA1—Metabolism—TPI1—osteoporosis	3.83e-05	0.000551	CbGpPWpGaD
Topiramate—Rash—Conjugated Estrogens—osteoporosis	3.82e-05	0.000175	CcSEcCtD
Topiramate—Dermatitis—Conjugated Estrogens—osteoporosis	3.82e-05	0.000175	CcSEcCtD
Topiramate—CA12—Metabolism—ENO1—osteoporosis	3.8e-05	0.000546	CbGpPWpGaD
Topiramate—Headache—Conjugated Estrogens—osteoporosis	3.8e-05	0.000174	CcSEcCtD
Topiramate—CA2—Metabolism—P4HB—osteoporosis	3.76e-05	0.00054	CbGpPWpGaD
Topiramate—CA4—Metabolism—RAP1A—osteoporosis	3.75e-05	0.000539	CbGpPWpGaD
Topiramate—CA12—Metabolism—PSMA2—osteoporosis	3.74e-05	0.000538	CbGpPWpGaD
Topiramate—CA12—Metabolism—PSMA5—osteoporosis	3.74e-05	0.000538	CbGpPWpGaD
Topiramate—Nausea—Zoledronate—osteoporosis	3.74e-05	0.000171	CcSEcCtD
Topiramate—CA9—Metabolism—CYP27A1—osteoporosis	3.72e-05	0.000535	CbGpPWpGaD
Topiramate—CA2—Metabolism—GAPDH—osteoporosis	3.69e-05	0.00053	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.67e-05	0.000527	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.63e-05	0.000521	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.62e-05	0.000521	CbGpPWpGaD
Topiramate—CA9—Metabolism—ACP5—osteoporosis	3.62e-05	0.000521	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.62e-05	0.00052	CbGpPWpGaD
Topiramate—CA1—Metabolism—P4HB—osteoporosis	3.6e-05	0.000518	CbGpPWpGaD
Topiramate—Nausea—Conjugated Estrogens—osteoporosis	3.6e-05	0.000165	CcSEcCtD
Topiramate—CA2—Metabolism—RAP1A—osteoporosis	3.59e-05	0.000516	CbGpPWpGaD
Topiramate—Hypersensitivity—Estradiol—osteoporosis	3.57e-05	0.000164	CcSEcCtD
Topiramate—CA1—Metabolism—GAPDH—osteoporosis	3.54e-05	0.000508	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP19A1—osteoporosis	3.51e-05	0.000505	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP19A1—osteoporosis	3.51e-05	0.000505	CbGpPWpGaD
Topiramate—Asthenia—Estradiol—osteoporosis	3.48e-05	0.000159	CcSEcCtD
Topiramate—GABRA1—Neuronal System—ADCY5—osteoporosis	3.46e-05	0.000497	CbGpPWpGaD
Topiramate—CA1—Metabolism—RAP1A—osteoporosis	3.44e-05	0.000495	CbGpPWpGaD
Topiramate—Pruritus—Estradiol—osteoporosis	3.43e-05	0.000157	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—IL6R—osteoporosis	3.39e-05	0.000488	CbGpPWpGaD
Topiramate—CA9—Metabolism—TPI1—osteoporosis	3.37e-05	0.000484	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6R—osteoporosis	3.34e-05	0.00048	CbGpPWpGaD
Topiramate—Diarrhoea—Estradiol—osteoporosis	3.32e-05	0.000152	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	3.31e-05	0.000476	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP19A1—osteoporosis	3.28e-05	0.000471	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP19A1—osteoporosis	3.28e-05	0.000471	CbGpPWpGaD
Topiramate—Dizziness—Estradiol—osteoporosis	3.21e-05	0.000147	CcSEcCtD
Topiramate—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	3.2e-05	0.00046	CbGpPWpGaD
Topiramate—CA9—Metabolism—P4HB—osteoporosis	3.17e-05	0.000455	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	3.16e-05	0.000454	CbGpPWpGaD
Topiramate—CA9—Metabolism—GAPDH—osteoporosis	3.11e-05	0.000447	CbGpPWpGaD
Topiramate—Vomiting—Estradiol—osteoporosis	3.08e-05	0.000141	CcSEcCtD
Topiramate—Rash—Estradiol—osteoporosis	3.06e-05	0.00014	CcSEcCtD
Topiramate—Dermatitis—Estradiol—osteoporosis	3.06e-05	0.00014	CcSEcCtD
Topiramate—Headache—Estradiol—osteoporosis	3.04e-05	0.000139	CcSEcCtD
Topiramate—CA12—Metabolism—CYP19A1—osteoporosis	3.04e-05	0.000436	CbGpPWpGaD
Topiramate—CA4—Metabolism—ENO1—osteoporosis	3.03e-05	0.000435	CbGpPWpGaD
Topiramate—CA9—Metabolism—RAP1A—osteoporosis	3.03e-05	0.000435	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.01e-05	0.000432	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.01e-05	0.000432	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSMA2—osteoporosis	2.98e-05	0.000429	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSMA5—osteoporosis	2.98e-05	0.000429	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.93e-05	0.000421	CbGpPWpGaD
Topiramate—CA2—Metabolism—ENO1—osteoporosis	2.9e-05	0.000417	CbGpPWpGaD
Topiramate—Nausea—Estradiol—osteoporosis	2.88e-05	0.000132	CcSEcCtD
Topiramate—CA6—Metabolism—ADCY5—osteoporosis	2.87e-05	0.000412	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ADCY5—osteoporosis	2.87e-05	0.000412	CbGpPWpGaD
Topiramate—CA2—Metabolism—PSMA2—osteoporosis	2.86e-05	0.000411	CbGpPWpGaD
Topiramate—CA2—Metabolism—PSMA5—osteoporosis	2.86e-05	0.000411	CbGpPWpGaD
Topiramate—CA6—Metabolism—GPX1—osteoporosis	2.86e-05	0.000411	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GPX1—osteoporosis	2.86e-05	0.000411	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—LEP—osteoporosis	2.85e-05	0.000409	CbGpPWpGaD
Topiramate—CA1—Metabolism—ENO1—osteoporosis	2.78e-05	0.0004	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSMA2—osteoporosis	2.74e-05	0.000394	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSMA5—osteoporosis	2.74e-05	0.000394	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.69e-05	0.000386	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ADCY5—osteoporosis	2.68e-05	0.000385	CbGpPWpGaD
Topiramate—CA7—Metabolism—ADCY5—osteoporosis	2.68e-05	0.000385	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	2.67e-05	0.000384	CbGpPWpGaD
Topiramate—CA7—Metabolism—GPX1—osteoporosis	2.67e-05	0.000384	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GPX1—osteoporosis	2.67e-05	0.000384	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000379	CbGpPWpGaD
Topiramate—CA6—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000379	CbGpPWpGaD
Topiramate—CA12—Metabolism—ADCY5—osteoporosis	2.48e-05	0.000357	CbGpPWpGaD
Topiramate—CA12—Metabolism—GPX1—osteoporosis	2.47e-05	0.000355	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—osteoporosis	2.46e-05	0.000354	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—osteoporosis	2.46e-05	0.000354	CbGpPWpGaD
Topiramate—CA9—Metabolism—ENO1—osteoporosis	2.45e-05	0.000352	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP19A1—osteoporosis	2.42e-05	0.000348	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSMA2—osteoporosis	2.41e-05	0.000347	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSMA5—osteoporosis	2.41e-05	0.000347	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6R—osteoporosis	2.38e-05	0.000343	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.34e-05	0.000337	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.33e-05	0.000334	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP19A1—osteoporosis	2.32e-05	0.000334	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—osteoporosis	2.28e-05	0.000328	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP19A1—osteoporosis	2.23e-05	0.00032	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	2.18e-05	0.000313	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.18e-05	0.000313	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.13e-05	0.000306	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—osteoporosis	2.12e-05	0.000305	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—osteoporosis	2.12e-05	0.000304	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—osteoporosis	2.11e-05	0.000303	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—osteoporosis	2.11e-05	0.000303	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—osteoporosis	2e-05	0.000288	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.99e-05	0.000286	CbGpPWpGaD
Topiramate—CA4—Metabolism—ADCY5—osteoporosis	1.98e-05	0.000284	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPX1—osteoporosis	1.97e-05	0.000283	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—osteoporosis	1.97e-05	0.000283	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—osteoporosis	1.97e-05	0.000283	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP19A1—osteoporosis	1.96e-05	0.000281	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.93e-05	0.000277	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—osteoporosis	1.92e-05	0.000277	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.9e-05	0.000273	CbGpPWpGaD
Topiramate—CA2—Metabolism—ADCY5—osteoporosis	1.9e-05	0.000273	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPX1—osteoporosis	1.89e-05	0.000272	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—osteoporosis	1.87e-05	0.000269	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.86e-05	0.000267	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—osteoporosis	1.82e-05	0.000262	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—osteoporosis	1.82e-05	0.000262	CbGpPWpGaD
Topiramate—CA1—Metabolism—ADCY5—osteoporosis	1.82e-05	0.000261	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FDPS—osteoporosis	1.82e-05	0.000261	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PKM—osteoporosis	1.82e-05	0.000261	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPX1—osteoporosis	1.81e-05	0.00026	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.76e-05	0.000253	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—osteoporosis	1.74e-05	0.000251	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPD2—osteoporosis	1.72e-05	0.000247	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PGLS—osteoporosis	1.72e-05	0.000247	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—osteoporosis	1.67e-05	0.00024	CbGpPWpGaD
Topiramate—CA9—Metabolism—ADCY5—osteoporosis	1.6e-05	0.00023	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—osteoporosis	1.59e-05	0.000229	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PNP—osteoporosis	1.57e-05	0.000226	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ATIC—osteoporosis	1.57e-05	0.000226	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—osteoporosis	1.51e-05	0.000217	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—osteoporosis	1.49e-05	0.000214	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—osteoporosis	1.47e-05	0.000211	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—osteoporosis	1.46e-05	0.000209	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—osteoporosis	1.41e-05	0.000203	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—osteoporosis	1.39e-05	0.000201	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—OXCT1—osteoporosis	1.34e-05	0.000192	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA2—osteoporosis	1.34e-05	0.000192	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—osteoporosis	1.34e-05	0.000192	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—osteoporosis	1.32e-05	0.000189	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MGLL—osteoporosis	1.3e-05	0.000187	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.23e-05	0.000177	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—osteoporosis	1.18e-05	0.000169	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—osteoporosis	1.16e-05	0.000166	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH2—osteoporosis	1.11e-05	0.000159	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FDPS—osteoporosis	1.09e-05	0.000157	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PKM—osteoporosis	1.09e-05	0.000157	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—osteoporosis	1.06e-05	0.000153	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.04e-05	0.00015	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PGLS—osteoporosis	1.03e-05	0.000149	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPD2—osteoporosis	1.03e-05	0.000149	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACP5—osteoporosis	1.01e-05	0.000146	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1e-05	0.000144	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PNP—osteoporosis	9.46e-06	0.000136	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ATIC—osteoporosis	9.46e-06	0.000136	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TPI1—osteoporosis	9.43e-06	0.000136	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—P4HB—osteoporosis	8.87e-06	0.000127	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GAPDH—osteoporosis	8.7e-06	0.000125	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RAP1A—osteoporosis	8.48e-06	0.000122	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA2—osteoporosis	8.05e-06	0.000116	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—OXCT1—osteoporosis	8.05e-06	0.000116	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MGLL—osteoporosis	7.84e-06	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.39e-06	0.000106	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO1—osteoporosis	6.85e-06	9.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMA5—osteoporosis	6.75e-06	9.7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMA2—osteoporosis	6.75e-06	9.7e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH2—osteoporosis	6.67e-06	9.59e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.27e-06	9.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACP5—osteoporosis	6.1e-06	8.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TPI1—osteoporosis	5.67e-06	8.15e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP19A1—osteoporosis	5.48e-06	7.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—P4HB—osteoporosis	5.33e-06	7.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GAPDH—osteoporosis	5.23e-06	7.52e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RAP1A—osteoporosis	5.1e-06	7.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADCY5—osteoporosis	4.47e-06	6.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—osteoporosis	4.46e-06	6.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO1—osteoporosis	4.12e-06	5.92e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—osteoporosis	4.12e-06	5.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMA5—osteoporosis	4.06e-06	5.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMA2—osteoporosis	4.06e-06	5.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.29e-06	4.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—osteoporosis	3.29e-06	4.73e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADCY5—osteoporosis	2.69e-06	3.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—osteoporosis	2.68e-06	3.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—osteoporosis	2.47e-06	3.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—osteoporosis	1.98e-06	2.85e-05	CbGpPWpGaD
